Cite
HARVARD Citation
Scheers, E. et al. (2021). Metabolism and disposition in rats, dogs, and humans of erdafitinib, an orally administered potent pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor. Xenobiotica. pp. 177-193. [Online].